D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 78 Citations 14,823 365 World Ranking 13092 National Ranking 415

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

Masayuki Nakagawa spends much of his time researching microRNA, Cancer, Cancer research, Molecular biology and Cell growth. His microRNA research is multidisciplinary, relying on both Gene expression, Carcinogenesis, RNA interference, Regulation of gene expression and Gene silencing. His Cancer research is multidisciplinary, incorporating elements of Oncology and Transfection.

He combines subjects such as Bladder cancer, RNA, Cell cycle, Oncogene and Tumor suppressor gene with his study of Cancer research. His biological study spans a wide range of topics, including Camptothecin, Cell culture, Northern blot and Gene expression profiling. His Cell growth study combines topics in areas such as Cell cycle checkpoint and Apoptosis.

His most cited work include:

  • miR‐145, miR‐133a and miR‐133b: Tumor‐suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma (366 citations)
  • Identification of novel microRNA targets based on microRNA signatures in bladder cancer. (348 citations)
  • miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer (262 citations)

What are the main themes of his work throughout his whole career to date?

Masayuki Nakagawa mostly deals with Cancer research, microRNA, Cancer, Internal medicine and Oncology. His research integrates issues of Bladder cancer, Carcinogenesis, Renal cell carcinoma, Metastasis and Prostate cancer in his study of Cancer research. His work carried out in the field of microRNA brings together such families of science as Gene expression, Cell growth, Molecular biology, Cell cycle and Gene silencing.

His Molecular biology study integrates concerns from other disciplines, such as Cell culture and Gene expression profiling. His Cancer study incorporates themes from Signal transduction, Gene and Pathology. His Internal medicine research includes elements of Gastroenterology, Endocrinology and DNA methylation.

He most often published in these fields:

  • Cancer research (44.81%)
  • microRNA (38.80%)
  • Cancer (25.96%)

What were the highlights of his more recent work (between 2015-2021)?

  • Cancer research (44.81%)
  • microRNA (38.80%)
  • Bladder cancer (14.75%)

In recent papers he was focusing on the following fields of study:

His main research concerns Cancer research, microRNA, Bladder cancer, Internal medicine and Renal cell carcinoma. Masayuki Nakagawa has included themes like Cell growth, Carcinogenesis, Apoptosis, Clear cell renal cell carcinoma and Sunitinib in his Cancer research study. His Carcinogenesis research focuses on Cell cycle and how it relates to Regulation of gene expression.

The microRNA study combines topics in areas such as Cancer cell, Cancer, Metastasis, Cell culture and Gene silencing. His studies deal with areas such as Molecular biology, Surgical oncology and Gene as well as Cancer. Masayuki Nakagawa interconnects Gastroenterology, Oncology and Microrna 26a in the investigation of issues within Internal medicine.

Between 2015 and 2021, his most popular works were:

  • Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer. (89 citations)
  • Tumor‐suppressive microRNA‐223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer (76 citations)
  • Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 ( miR-145-5p and miR-145-3p ): inhibition of bladder cancer cell aggressiveness (71 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Masayuki Nakagawa focuses on microRNA, Cancer research, Cell growth, Bladder cancer and Cancer. His research in microRNA intersects with topics in Cell culture, Carcinogenesis, Metastasis, Regulation of gene expression and Gene silencing. His Cancer research research integrates issues from Apoptosis, Cell cycle, Gene knockdown, Clear cell renal cell carcinoma and Sunitinib.

His work in Cell growth addresses issues such as Cell, which are connected to fields such as Cell biology. His work deals with themes such as Gene, Position paper and General surgery, which intersect with Bladder cancer. Masayuki Nakagawa focuses mostly in the field of Cancer, narrowing it down to matters related to Molecular biology and, in some cases, Cell migration and Transfection.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma

Masayuki Kano;Naohiko Seki;Naoko Kikkawa;Lisa Fujimura.
International Journal of Cancer (2010)

531 Citations

Identification of novel microRNA targets based on microRNA signatures in bladder cancer.

Takahiro Ichimi;Hideki Enokida;Yasushi Okuno;Ryo Kunimoto.
International Journal of Cancer (2009)

490 Citations

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

T Chiyomaru;H Enokida;S Tatarano;K Kawahara.
British Journal of Cancer (2010)

379 Citations

Prognostic value of tumor-associated macrophage count in human bladder cancer

Toshikatsu Hanada;Masayuki Nakagawa;Akio Emoto;Takeo Nomura.
International Journal of Urology (2000)

345 Citations

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer

H Yoshino;T Chiyomaru;H Enokida;K Kawakami.
British Journal of Cancer (2011)

303 Citations

MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology

Yasutoshi Yamada;Hideki Enokida;Satoko Kojima;Kazumori Kawakami.
Cancer Science (2011)

261 Citations

Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR

Takeshi Chiyomaru;Soichiro Yamamura;Shinichiro Fukuhara;Hirofumi Yoshino.
PLOS ONE (2013)

256 Citations

Combination Analysis of Hypermethylated Wnt-Antagonist Family Genes as a Novel Epigenetic Biomarker Panel for Bladder Cancer Detection

Shinji Urakami;Hiroaki Shiina;Hideki Enokida;Toshifumi Kawakami.
Clinical Cancer Research (2006)

235 Citations

Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase ( PNP ) in prostate cancer

S Kojima;T Chiyomaru;K Kawakami;H Yoshino.
British Journal of Cancer (2012)

223 Citations

Aberrant expression of microRNAs in bladder cancer

Hirofumi Yoshino;Naohiko Seki;Toshihiko Itesako;Takeshi Chiyomaru.
Nature Reviews Urology (2013)

222 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Masayuki Nakagawa

Naohiko Seki

Naohiko Seki

Chiba University

Publications: 63

Rajvir Dahiya

Rajvir Dahiya

University of California, San Francisco

Publications: 40

Kimitoshi Kohno

Kimitoshi Kohno

University of Occupational and Environmental Health Japan

Publications: 29

Michihiko Kuwano

Michihiko Kuwano

Kyushu University

Publications: 22

Liang Cheng

Liang Cheng

Indiana University

Publications: 18

Leland W.K. Chung

Leland W.K. Chung

Cedars-Sinai Medical Center

Publications: 17

Hiroto Izumi

Hiroto Izumi

University of Occupational and Environmental Health Japan

Publications: 17

Stefano Fais

Stefano Fais

Istituto Superiore di Sanità

Publications: 16

George M. Yousef

George M. Yousef

University of Toronto

Publications: 14

Shin-ichi Akiyama

Shin-ichi Akiyama

Kagoshima University

Publications: 13

Tomoyuki Sumizawa

Tomoyuki Sumizawa

Kagoshima University

Publications: 12

Zhe-Sheng Chen

Zhe-Sheng Chen

St. John's University

Publications: 12

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 12

Yoshitaka Okamoto

Yoshitaka Okamoto

Chiba University

Publications: 12

Yuji Hinoda

Yuji Hinoda

Yamaguchi University

Publications: 12

Shoji Natsugoe

Shoji Natsugoe

Kagoshima University

Publications: 11

Trending Scientists

Daniel D. Gajski

Daniel D. Gajski

University of California, Irvine

Zhi Tian

Zhi Tian

George Mason University

Rodolphe Clérac

Rodolphe Clérac

Paul Pascal Research Center

Masaki Azuma

Masaki Azuma

Tokyo Institute of Technology

Anna Kuparinen

Anna Kuparinen

University of Jyväskylä

Fredrik Pontén

Fredrik Pontén

Uppsala University

Shankar Subramaniam

Shankar Subramaniam

University of California, San Diego

Eric S. Daar

Eric S. Daar

Lundquist Institute

Tom Eirik Mollnes

Tom Eirik Mollnes

Oslo University Hospital

Mariët Hagedoorn

Mariët Hagedoorn

University Medical Center Groningen

David A. Frederick

David A. Frederick

Chapman University

Christian Herfarth

Christian Herfarth

Heidelberg University

Russell E. Ware

Russell E. Ware

Cincinnati Children's Hospital Medical Center

Nancy K. Mello

Nancy K. Mello

Harvard University

Nicole C. Krämer

Nicole C. Krämer

University of Duisburg-Essen

Roberta Romano

Roberta Romano

Yale University

Something went wrong. Please try again later.